Ledger.Open graph →

SEC Form D · Amendment · filed December 6, 2010

PhaseBio Pharmaceuticals Inc

Offering

$25.3M

Sold

$25.3M

Exemption

—

Industry

Biotechnology

Location

Malvern, PA

Type

—

People & firms on this filing (20)

James Barrett · Baltimore, MDDirector Guy Fish · Boston, MADirector Barry L. Boniface · Atlanta, GAExec John E. Kingma · SEATTLE, WADirector Robert Ingram · Durham, NCDirector Craig Rosen · Pasadena, MDDirector Ashutosh Chilkoti · Durham, NCDirector Justin Klein · Chevy Chase, MDDirector Christopher Prior · Malvern, PAExec · Director Clay Thorp · Durham, NCDirector Michael D. Long · Atlanta, GAExec Jeffery L. Henry · Bend, ORDirector Scott L. Bolding · Fayetteville, ARDirector Kenneth Rogers · Waterford, MIDirector Thomas E. Kimble · Waterford, MIDirector John H. Welker · Waterford, MIDirector Michael O'Malley · EBENE, O4Exec · Director Simon P. Fifield · EBENE, O4Director Duncan J. Westcott · EBENE, O4Director York Shin J. Lim Voon Kee · EBENE, O4Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗